» Articles » PMID: 22547939

Five-year Follow-up of a Woman with Pregnancy and Lactation-associated Osteoporosis and Vertebral Fractures

Overview
Publisher Dove Medical Press
Date 2012 May 2
PMID 22547939
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We report the 5-year follow-up of a young woman who developed vertebral fractures after pregnancy and lactation and was treated with active vitamin D hormone. A 32-year-old Japanese woman consulted us because of acute lower back pain caused by L2 and L5 vertebral fractures after pregnancy and lactation. Following cessation of breast-feeding, analgesia, bed rest, and wearing of a hard brace, her lower back pain disappeared within 2 months. After 5 years of treatment with alfacalcidol 1 μg daily, the lumbar spine (L1, L3, L4) bone mineral density increased by 21.4% following vigorous reductions in bone turnover markers. No osteoporotic fractures occurred, and the vertebral fractures healed. The patient experienced no side effects, including hypercalcemia. Thus, the present case report shows long-term changes in bone turnover markers and lumbar spine bone mineral density, as well as long-term safety of alfacalcidol treatment in a young woman with pregnancy and lactation-associated osteoporosis and vertebral fractures.

Citing Articles

Pregnancy- and lactation-related bone fragility: The hidden risk.

Unal M, Sacinti K, Sezgin E Jt Dis Relat Surg. 2024; 36(1):210-213.

PMID: 39719919 PMC: 11734854. DOI: 10.52312/jdrs.2024.1957.


Multiple Vertebral Compression Fractures Secondary to Pregnancy-induced Osteoporosis: A Case Report.

Davey M, Staunton P, Mohan K, Tatro E, Baker J, Devitt A J Orthop Case Rep. 2024; 14(6):101-107.

PMID: 38910989 PMC: 11189080. DOI: 10.13107/jocr.2024.v14.i06.4518.


A Scoping Review of the Apparent Phenomenon of the Improvement in Hypoparathyroidism in Pregnant and Postpartum Females.

John Levy Barnett M Cureus. 2023; 15(9):e46123.

PMID: 37790033 PMC: 10544865. DOI: 10.7759/cureus.46123.


Comparative Effectiveness of Therapeutic Interventions in Pregnancy and Lactation-Associated Osteoporosis: A Systematic Review and Meta-analysis.

Anagnostis P, Lampropoulou-Adamidou K, Bosdou J, Trovas G, Galanis P, Chronopoulos E J Clin Endocrinol Metab. 2023; 109(3):879-901.

PMID: 37708365 PMC: 10876413. DOI: 10.1210/clinem/dgad548.


Pregnancy- and lactation-associated osteoporosis with vertebral fractures: a systematic review.

Qian Y, Wang L, Yu L, Huang W BMC Musculoskelet Disord. 2021; 22(1):926.

PMID: 34732196 PMC: 8567545. DOI: 10.1186/s12891-021-04776-7.


References
1.
Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M . Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab. 2001; 19(6):331-7. DOI: 10.1007/s007740170001. View

2.
Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S . Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int. 1994; 54(5):370-6. DOI: 10.1007/BF00305521. View

3.
Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Taga M, Nakamura T . A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group. Osteoporos Int. 1999; 10(3):183-92. DOI: 10.1007/s001980050214. View

4.
Yoon B, Lee J, Choi D, Roh C, Lee J . Changes in biochemical bone markers during pregnancy and puerperium. J Korean Med Sci. 2000; 15(2):189-93. PMC: 3054614. DOI: 10.3346/jkms.2000.15.2.189. View

5.
Khovidhunkit W, Epstein S . Osteoporosis in pregnancy. Osteoporos Int. 1996; 6(5):345-54. DOI: 10.1007/BF01623007. View